Article
Zidovudine treatment is not associated with HTLV-1 reverse transcriptase gene mutations in HTLV-I/HIV-1 co-infected patients.
Antiviral therapy - 1 Apr 1997
Gasmi M, Fillon S, Leriche K, Neisson-Vernant C, Desgranges C
Abstract excerpt
Zidovudine treatment of human immunodeficiency virus (HIV) infection induces drug-resistant viral strains harbouring specific amino acid substitutions in the reverse transcriptase (RT). To investigate whether this phenomenon could be observed in the case of human T lymphotropic virus type I (HTLV...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
